Cardiac Wire

We already know that what you put in your body is directly related to your overall health, including cardiovascular risk, but a new JACC study suggests your ethnic background could impact just how much damage ultraprocessed foods do to your body. cardiacwire.com/ultraprocessed…

@SCAI @AmierHaidar @vonBardelebenRS @AndreZimerman

In the latest Cardiac Wire, we discuss… 🫀Ultraprocessed Foods are Bad for Everyone and Worse for Some 🫀The New Lipid Guidelines 🫀Antidepressants and the Heart And more cardiology news: cardiacwire.com/newsletter/ult…

JACC released its inaugural Cardiovascular Statistics 2026 report covering a wide spectrum of major CV risk factors and conditions, and despite the medical advancements in the last ten years, it’s clear we still have a lot of work left to do. cardiacwire.com/where-weve-bee…

In the latest Cardiac Wire, we discuss… 🫀Where We’ve Been, and Where We’re Going in CV Health 🫀Bringing Ablation to ASCs 🫀@swordhealth Pulse Debut And more cardiology news: cardiacwire.com/newsletter/jac…

New follow-up data from the RENOVATE-COMPLEX-PCI trial suggests that intravascular imaging continues to provide better clinical outcomes for patients with complex coronary lesions five years after their PCI procedure. cardiacwire.com/ivi-or-angiogr…

@TenayaThera @AmineMazineMD @NimeshDesaiMD @KevinQ_Chen

In the latest Cardiac Wire, we discuss… 🫀IVI or Angiography for Complex PCI Guidance? 🫀Suspended Lead Suits Reduce Radiation 🫀@Philips Gets Cardiac MRI Software Clearance And more cardiology news: cardiacwire.com/newsletter/ivi…

Strong results from two separate studies on CVRx’s Barostim baroreflex activation therapy suggest the technology might offer symptomatic relief even though its mortality benefit is still up in the air. cardiacwire.com/barostim-boost…

@HeartBeamInc @ASCENDCV @inflohealth @NirUrielMD

In the latest Cardiac Wire, we discuss… 🫀Barostim Boosts QoL and LVEF, but Mortality Benefit Still Unknown 🫀Beta Blockers Bad for nHCM 🫀HBR in MI Patients And more cardiology news: cardiacwire.com/newsletter/bar…

New research presented at THT 2026 suggests that the NT-proBNP biomarker could give us a glimpse into which patients with severe tricuspid regurgitation (TR) will benefit the most from transcatheter edge-to-edge repair (TEER). cardiacwire.com/what-nt-probnp…

@ChiesiGRD @AbbottNews

In the latest Cardiac Wire, we discuss… 🫀What NT-proBNP Can Tell Us About TEER Outcomes 🫀Squeezing Limbs to Protect Hearts 🫀Relief’s Relieving FIH And more cardiology news: cardiacwire.com/newsletter/nt-…

There might be a bigger difference between the types of cardiac troponin assays, after a recent JACC analysis found that the type of troponin could help us better understand the kind of damage occurring after a heart attack. cardiacwire.com/two-cardiac-tr…

@GSK @novonordisk @DorienKimenai @EmeliaBenjamin @AnnaApostolopo3 @M_M_Mohiuddin

In the latest Cardiac Wire, we discuss… 🫀Two Cardiac Troponins Don’t Tell the Same Story 🫀A Path to Xenotransplantation 🫀Echo AI Aids Cardiac Amyloidosis Detection And more cardiology news: cardiacwire.com/newsletter/car…

The American Heart Association's latest scientific statement paints a grim picture of women’s cardiovascular health by 2050. cardiacwire.com/womens-cvd-wil…

@Cara_Medical @gentuity @AeyeHealth @EdwardsLifesci @ChemifyX @BIOTRONIK_US @kejoynt

In the latest Cardiac Wire, we discuss… 🫀Women’s CVD Will Keep Rising by 2050 🫀Cardiac Imaging Radiation Dose Varies 🫀Bacterial Metabolites and the Heart And more cardiology news: cardiacwire.com/newsletter/wom…